DE60103940D1 - Stabilisierter Granulozyten-Kolonie-stimulierender Faktor - Google Patents

Stabilisierter Granulozyten-Kolonie-stimulierender Faktor

Info

Publication number
DE60103940D1
DE60103940D1 DE60103940T DE60103940T DE60103940D1 DE 60103940 D1 DE60103940 D1 DE 60103940D1 DE 60103940 T DE60103940 T DE 60103940T DE 60103940 T DE60103940 T DE 60103940T DE 60103940 D1 DE60103940 D1 DE 60103940D1
Authority
DE
Germany
Prior art keywords
stimulating factor
colony stimulating
granulocyte colony
stabilized
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60103940T
Other languages
English (en)
Other versions
DE60103940T2 (de
Inventor
Josephine Nanette Hay
Kathleen Brimelow Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60103940D1 publication Critical patent/DE60103940D1/de
Publication of DE60103940T2 publication Critical patent/DE60103940T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60103940T 2000-02-29 2001-02-21 Stabilisierter Granulozyten-Kolonie-stimulierender Faktor Expired - Fee Related DE60103940T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18576900P 2000-02-29 2000-02-29
US185769P 2000-02-29

Publications (2)

Publication Number Publication Date
DE60103940D1 true DE60103940D1 (de) 2004-07-29
DE60103940T2 DE60103940T2 (de) 2005-07-28

Family

ID=22682387

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103940T Expired - Fee Related DE60103940T2 (de) 2000-02-29 2001-02-21 Stabilisierter Granulozyten-Kolonie-stimulierender Faktor

Country Status (11)

Country Link
US (1) US6497869B2 (de)
EP (1) EP1129720B1 (de)
JP (1) JP3544180B2 (de)
AT (1) ATE269716T1 (de)
BR (1) BR0100827A (de)
CA (1) CA2337661A1 (de)
DE (1) DE60103940T2 (de)
DK (1) DK1129720T3 (de)
ES (1) ES2220673T3 (de)
PT (1) PT1129720E (de)
TR (1) TR200401573T4 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
ATE482716T1 (de) * 2001-11-13 2010-10-15 Genentech Inc Zusammensetzungen basierend auf apo2-ligand/ trail und ihre verwendung
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
EP1682184B1 (de) 2003-11-04 2013-10-16 LEK Pharmaceuticals d.d. Stabile pharmazeutische zubereitungen enthaltend granulozyten-kolonie stimulierungsfaktor
JP2008542430A (ja) * 2005-06-06 2008-11-27 ノボ・ノルデイスク・エー／エス 安定化ｉｌ−２１組成物
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
DE202007018629U1 (de) 2007-08-27 2008-12-24 Biogenerix Ag Flüssigformulierung von G-CSF
CA2697376C (en) 2007-08-27 2016-07-19 Walter Hinderer Liquid formulation of g-csf
US10138283B2 (en) 2008-07-23 2018-11-27 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
JP5769379B2 (ja) * 2010-03-17 2015-08-26 グンゼ株式会社 Ｄａｎｃｅタンパク質溶液
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
AU2016342210A1 (en) * 2015-10-19 2018-05-10 Sandoz Ag Method for producing a recombinant protein with reduced impurities

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
GB2193621A (en) 1986-07-29 1988-02-17 Jan Mazura Plant support line
WO1989010932A1 (en) 1988-05-13 1989-11-16 Amgen Inc. Compositions and method for treating or preventing infections in animals
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
JPH04502164A (ja) 1989-10-10 1992-04-16 アムジエン・インコーポレーテツド 犬科・猫科動物における感染の治療または予防のための化学組成物及び方法
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
IE912365A1 (en) 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
FR2686900B1 (fr) 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
FR2693907B1 (fr) 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
DE4242863A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
EP0710102A1 (de) 1993-07-19 1996-05-08 Amgen Inc. Stabilisierung von proteinen in aerosolform
US5874075A (en) 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
PT988861E (pt) * 1998-08-17 2004-06-30 Pfizer Prod Inc Formulacoes de proteina estabilizadas

Also Published As

Publication number Publication date
DE60103940T2 (de) 2005-07-28
JP3544180B2 (ja) 2004-07-21
EP1129720A2 (de) 2001-09-05
TR200401573T4 (tr) 2004-08-23
US20020002133A1 (en) 2002-01-03
ATE269716T1 (de) 2004-07-15
US6497869B2 (en) 2002-12-24
EP1129720A3 (de) 2001-09-26
CA2337661A1 (en) 2001-08-29
BR0100827A (pt) 2001-11-27
PT1129720E (pt) 2004-08-31
DK1129720T3 (da) 2004-09-27
EP1129720B1 (de) 2004-06-23
JP2001278898A (ja) 2001-10-10
ES2220673T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
DE60103940D1 (de) Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
DE60219383D1 (de) Wässrige Beschichtungszusammensetzung
PL369024A1 (en) Arthropodicidal anthranilamides
DE60123389D1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
MX355976B (es) Composiciones antitranspirantes de eficacia mejorada que contienen estroncio.
TW200724159A (en) Stable emulsion composition
ATE305765T1 (de) Haarwachstumsfördernde zusammensetzungen
EP1236398A4 (de) Mikrobizide zusammensetzungen
WO2002017921A3 (en) Paroxetine compositions and processes for making the same
GB0015027D0 (en) Aqueous coating composition
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
HRP20030433B1 (en) Dermatological formulations containing clindamycin and a zinc-salt
DE60001302T2 (de) Wässrige Beschichtungszusammensetzung
ATE536886T1 (de) Stabilisierte feste zusammensetzungen von modifizierter faktor vii
MXPA03007757A (es) Composiciones que contienen creatina y creatinina.
CY1108791T1 (el) Φυτοενδυναμωτικο μεσον
DE60113659D1 (de) Orale zusammensetzung enthaltend 2'-hydroxypropiophenon
DK1100329T3 (da) Vækstregulerende vandige sammensætninger
GB0020965D0 (en) Improvements in or relating to aqueous compositions
ATE506989T1 (de) Harnstoffhaltige haarglättungszusammensetzung
ES2194591A1 (es) Composicion en forma de emulsion adecuada para la elaboracion de productos desodorantes.
CA2185549A1 (en) Stable strongly acidic aqueous compositions containing persulfate salts
ATE378471T1 (de) Wässrige zusammensetzung aus polyamidoaminen und tensiden zur papierherstellung
WO2002056896A3 (de) Behandlungslösung sowie verbandmaterial für die wundversorgung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee